Catalyst Scientific Advisory Board

Richard B. Silverman, PhD

Richard B. Silverman, PhD, is a renowned expert in the field of rational drug design, on the biochemistry of GABA aminotransferase, and on CPP-115. He is the John Evans Professor of Chemistry at Northwestern University and holds 42 patents. He is the inventor of Pfizer's $3 billion Lyrica^® (pregabalin), marketed worldwide for the treatment of epilepsy, neuropathic pain, fibromyalgia, and (in Europe) for generalized anxiety disorder. He has received numerous awards, most recently the 2011 E.B. Hershberg Award for Important Discoveries in Medicinally Active Sub­stances and the 2009 Perkin Medal, both from the American Chemical Society. Dr. Silverman has published over 285 peer-reviewed articles and has written four books over his 34-year career in academia. Complete details of Dr. Silverman's achievements can be found at http://chemgroups.northwestern.edu/silverman/.

Scientific Advisory Board

• Stephen L. Dewey, PhD – Chairman
• Jonathan Brodie, PhD, MD
• Robert D. Fechtner, MD
• Thomas Kosten, MD
• Eugene Laska, PhD
• Richard A. Rawson, PhD
• Richard B. Silverman, PhD